ROIVW (Roivant Sciences) GF Score: 55/100 (As of Jun. 28, 2026) — 175% Above Median


ROIVW Roivant Sciences Ltd ROIVW
55 GF Score
Price $2.75
! 7 Warning Signs
View Full Analysis

What is Roivant Sciences GF Score?

Roivant Sciences ROIVW -3.85% 55 GF Score is 55 as of Jun. 28, 2026, which is 175% above its 10-year median of 20.00. GuruFocus rates ROIVW with a GF Score™ of 55/100. The stock has 7 warning signs investors should review.

Roivant Sciences has the GF Score of 55, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 7/10
2. Profitability Rank : 1/10
3. Growth Rank : 6/10
4. GF Value Rank : 1/10
5. Momentum Rank : 6/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Roivant Sciences might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Roivant Sciences  (NAS:ROIVW) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Roivant Sciences GF Score Related Terms

ROIVW vs INSM, INCY, BNTX: GF Score Comparison

For the Biotechnology subindustry, Roivant Sciences's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roivant Sciences GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roivant Sciences's GF Score distribution charts can be found below:

* The bar in red indicates where Roivant Sciences's GF Score falls into.


ROIVW
55GF Score
Roivant Sciences Ltd ROIVW
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 55 mean?
Roivant Sciences (ROIVW) has a GF Score of 55 as of Jun. 28, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Roivant Sciences and its competitors. This is 175% above median its historical median of 20.00. Over the past decade, Roivant Sciences' GF Score has ranged from 14.00 to 62.00.
Is Roivant Sciences' GF Score too high?
Roivant Sciences' current GF Score of 55 is 175% above median its 10-year median of 20.00. Over the past 10 years, this metric has ranged from a low of 14.00 to a high of 62.00. Overall, Roivant Sciences has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Roivant Sciences' GF Score compare to INSM and INCY?
Roivant Sciences' GF Score of 55 can be compared against companies in the Biotechnology industry. Historically, Roivant Sciences' own GF Score has ranged from 14.00 to 62.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Roivant Sciences and its competitors. Roivant Sciences's current GF Score is 55, which is 175% above median its own 10-year median of 20.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roivant Sciences stock overvalued right now?
Roivant Sciences (ROIVW) has a current GF Score of 55. The current GF Score is 55, which is 175% above median its 10-year median of 20.00. Roivant Sciences' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Roivant Sciences (ROIVW), the current GF Score is 55 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Roivant Sciences Business Description

Other Exchanges ROIV:USA87S:Germany
Address 50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
55GF Score

Get the complete analysis for ROIVW

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.75
Price